Nurix Therapeutics (NRIX) Cash & Equivalents (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Cash & Equivalents of $67.69 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 19.7% from $84.26 million a year earlier and down 4.9% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Cash & Equivalents of $246.96 million, up 124.5% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Equivalents came in at $110 million in FY2024 (+101.4%), $54.63 million in FY2023 (-15.3%), $64.47 million in FY2022 (-19.9%) and $80.51 million in FY2021 (-32.5%).
- The fiscal Q2 2026 figure is the lowest quarterly Cash & Equivalents since fiscal Q1 2024.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 42.2%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 134.1% in fiscal Q3 2024, against a decline of 77.9% in fiscal Q2 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $71.2 million (Q1 2026), $246.96 million (Q4 2025) and $78.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | 67.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 67.69 Mn |
| Feb 28, 2026 | 71.20 Mn |
| Nov 30, 2025 | 246.96 Mn |
| Aug 31, 2025 | 78.44 Mn |
| May 31, 2025 | 84.26 Mn |
| Feb 28, 2025 | 75.92 Mn |
| Nov 30, 2024 | 110.00 Mn |
| Aug 31, 2024 | 99.04 Mn |
| May 31, 2024 | 116.79 Mn |
| Feb 29, 2024 | 49.81 Mn |
| Nov 30, 2023 | 54.63 Mn |
| Aug 31, 2023 | 42.30 Mn |
| May 31, 2023 | 58.96 Mn |
| Feb 28, 2023 | 33.57 Mn |
| Nov 30, 2022 | 64.47 Mn |
| Aug 31, 2022 | 47.56 Mn |
| May 31, 2022 | 41.53 Mn |
| Feb 28, 2022 | 78.78 Mn |
| Nov 30, 2021 | 80.51 Mn |
| Aug 31, 2021 | 147.44 Mn |
API Access
Nurix Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();